KURA ONCOLOGY, INC. — Revenue by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6e746f14-59e3-4f55-826a-a7c88d27b998/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $67.5M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-092567 |
| FY 2024 | $53.9M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-029975 |
| FY 2023 | $0 | 2023-01-01 – 2023-12-31 | evidence 0001193125-26-092567 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
KURA ONCOLOGY, INC. — all facts · Net Income · Operating Income